The production value of basic pharmaceutical products and pharmaceutical preparations in Finland has shown a steady increase over the years. In 2023, the production value stood at 2.41 billion euros, with a year-on-year growth of 2.89% and a 5-year CAGR of 2.76%. Historical data indicates a robust trend, from 1.68 billion euros in 2014 to 2.34 billion euros in 2022. Forecasts suggest a continued upward trajectory, predicting a 2028 production value of 2.73 billion euros, with a forecasted 5-year CAGR of 1.97% and a cumulative growth of 10.26% over the same period.
Future trends to watch for:
- Technological Advancements: Growth in biotechnology and pharmaceutical innovations could drive higher production values.
- Regulatory Changes: Alterations in EU pharmaceutical regulations might impact production costs and volumes.
- Global Market Dynamics: Shifts in global demand and supply chains, especially post-pandemic, will influence market stability and growth opportunities.
